Former Johnson & Johnson ANZ Managing Director, Gavin Fox-Smith on working in large & small MedTech companies
Adelaide, South Australia wants to let the secret out, and be known as hub for medical devices, pharmaceuticals, biotechnology, and digital health. It boasts world-class research institutions, such as the University of Adelaide and SAHMRI, fostering innovation and collaboration. The city’s supportive government policies provide incentives, grants, and streamlined regulations for businesses. Adelaide’s skilled workforce, renowned for its expertise in health sciences, offers a talent pool to drive industry growth. Additionally, the city’s strategic location, advanced infrastructure, and strong healthcare ecosystem make it an ideal base for development, manufacturing, and market access, attracting companies in these sectors.
Edith de Boer is the HR Director for Zimmer Biomet in Australia and New Zealand. Her career originally was in telecommunications and consulting in Europe. After leaving The Netherlands, Edith worked into the Australian medical research industry, before moving into a human resources role at Zimmer Biomet. Edith spoke to Australian Health Journal about her role and the organisation.
Melbourne based Nutromics is looking to solve some of the biggest healthcare challenges, by delivering on a mission to revolutionise precision medicine with Continuous Molecular Monitoring (CMM). Nutromics is developing biosensor technology integrated into a small and unobtrusive wearable smart patch.The software solution aims to be flexible and designed to connect with mobile and web solutions for integration with consumer health software and hospital platforms.
MTAA’s annual conference is the premier medical technology industry conference in Australia and brings together leaders and influencers across industry, government and academia to discuss what’s up ahead for the MedTech industry.
Cicada Innovations with NSW Health this week hosted the graduation night for the 15 individuals that were part of the NSW Medical Device Commercialisation Training Program (MDCTP).
2018 marks the 10 year anniversary of the TAVI device, short for the Transcatheter Aortic Valve Implantation. The TAVI system enables the replacement of a diseased aortic valve without open-heart surgery or surgical removal of the native valve.
This minimally invasive surgical option reduces operating time and allows for a shortened recovery period for patients.
AHJ met with the cardiologist teams in Melbourne’s Epworth and Alfred Hospital who have involved in implanting the device over the past 10 years.
Australian Health Journal Episode 1 Professor Gregg Suaning of University of Sydney talks about the bionic eye and entering the clinical trial phase.